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APPsweAmyloid precursor protein (APP) has been a focus of intense investigation because of its role in Alzheimer's
disease (AD), however, its biological function remains uncertain. Loss of APP and APP-like proteins results in
postnatal lethality in mice, suggesting a role during embryogenesis. Here we show that in a zebraﬁsh model
system, knock down of APP results in the generation of ﬁsh with dramatically reduced body length and a
short, curly tail. In situ examination of gene expression suggests that the APP morphant embryos have
defective convergent-extension movements. We also show that wild-type human APP rescues the morphant
phenotype, but the Swedish mutant APP, which causes familial AD (fAD), does not rescue the developmental
defects. Collectively, this work demonstrates that the zebraﬁsh model is a powerful system to deﬁne the role
of APP during embryonic development and to evaluate the functional activity of fAD mutant APP.
© 2009 Elsevier Inc. All rights reserved.Introduction
Amyloid β precursor protein (APP), implicated in the etiology of
Alzheimer's disease (AD), is a neuronally enriched type I transmem-
brane protein of uncertain function (Zheng and Koo, 2006). APP is
constitutively cleaved by ‘secretases’, and its processing by β- and γ-
secretases results in the production of Aβ peptides (Selkoe andWolfe,
2007). Mutations in APP cause familial AD (fAD), and a leading
hypothesis suggests that these mutations promote the generation
and/or aggregation of Aβ peptides, which is the primary cause of the
disease (Hardy and Selkoe, 2002).
Much attention devoted to APP is focused on its role (and that of
Aβ) in AD, and relatively little is known about its normal in vivo
functions. In C. elegans, loss of the Apl gene (homologue of human
APP) severely affects developmental processes, resulting in larval
lethality (Hornsten et al., 2007). By comparison, deletion of Drosophila
APP-like protein (Appl) is not lethal but causes subtle behavioral
deﬁcits that are partially rescued by expressing human APP (Luo et al.,
1990). APP is highly expressed in the embryonic cortex in mice, and
knock down by siRNA impairs neuronal migration during develop-
ment (Young-Pearce et al., 2007). APP-knockout mice display subtle
neuromuscular and behavioral deﬁcits (Zheng et al., 1995), but
remain viable because highly homologous APP-like protein1 (APLP1)ll rights reserved.and APP-like protein2 (APLP2) compensate for the loss of APP
function (Heber et al., 2000; Muller et al., 1994; Zheng et al., 1995).
Double-knockout mice lacking APP and APLP2 or triple-knockout
animals lacking APP, APLP2 and APLP1 display cortical dysplasia of
type II lissencephaly (Herms et al., 2004) and die soon after birth
(Heber et al., 2000; von Koch et al., 1997). Together, these studies
support a role for the APP family proteins in neuronal migration
during embryonic development.
The zebraﬁsh model offers a powerful system to examine the
functional roles of a protein, especially during embryonic develop-
ment (Rohde and Heisenberg, 2007; Solnica-Krezel, 2006). Zebraﬁsh
embryos develop ex-utero, and their development is largely complete
within 72 h post fertilization (hpf). Due to their transparency, living
zebraﬁsh embryos can be readily viewed under a microscope.
Importantly, proteins can be overexpressed and knocked down by
injecting cappedmRNA and antisense morpholino (MO), respectively.
The zebraﬁsh genome shows signiﬁcant homology with the mouse
and human genomes. Indeed, the two zebraﬁsh APP proteins (APPa
and APPb) exhibit a high degree of homology with mouse and human
APP (Musa et al., 2001) making zebraﬁsh an ideal system to study APP
functions in vivo. We report here that knockdown of APP in zebraﬁsh
embryos leads to defective convergent-extension movements during
gastrulation. Importantly, wild-type human APP rescues these defects
to a large degree, but APP containing the familial Swedish mutation
(APPswe) does not rescue defective convergent-extension. Thus, the
zebraﬁsh system can reveal subtle functional differences in wild-type
and fAD mutant APP proteins during development.
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Zebraﬁsh stocks
Zebraﬁsh stocks were maintained at 28.5 °C and on a 14:10 h light
dark cycle using standard methods (Westerﬁeld, 2000). Wild-type
(Oregon AB) embryos were produced from natural matings, and used
for all of the experiments throughout this study.
Morpholino injections
Morpholino oligonucleotides for APPa and APPb, designed by and
purchased from Gene Tools LLC., were: APPa: 5′-ATGAAGAGCTCCTC-
GACCGCATGC-3′; APPb: 5′-TGTGTTCCCAAGCGCAGCACGTCC-3′. A
working solution of 10 mg/ml was made for each in Danieaux Buffer
(58 mM NaCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3), 5.0 mM HEPES pH
7.6) per the manufacturer's instructions, along with phenol red at a
ﬁnal concentration of 0.4% as a tracking dye. A generic standard
control-MO (5′-CCTCTTACCTCAGTTACAATTTATA) and missense
APPb-MO (5′-TGTcTTgCCAAGCcCAGCAgGTGCt) were also purchased
from Gene Tools and prepared similarly. 2.5 ng or 5 ng each of APPa
and APPb morpholinos together, or 10 ng individually, and similar
concentrations of generic standard control and missense MO were
injected into each embryo at the 1–2 cell stage using a Harvard
Apparatus PLI-90 picoinjector. The volume of the injection was 1 nl.
The embryos were maintained in standard temperature conditions in
a humid incubator.
Whole mount in situ hybridization
Whole mount RNA in situ hybridization was performed using
established methods (Liang et al., 2000). Antisense probes included
collagen type II, alpha-1a (col2a1a), paraxial protocadherin (papc), α-
tropomyosin (tpma) and sonic hedgehog (shh) (Krauss et al., 1993;
Xu et al., 2000; Yamamoto et al., 1998; Yan et al., 1995). Brieﬂy,
antisense probes were prepared using a Digoxigenin labeling kit
(Roche). The embryos were ﬁxed in 4% paraformaldehyde in PBS,
dechorionated, dehydrated, and stored in 100% methanol. The
embryos were re-hydrated, equilibrated with hybridization buffer
(0.625% formamide, 6.25% SSC, 0.0625mg/ml heparin, tRNA, 1.15mM
citric acid and 0.125% Tween-20) for 45 min, and incubated with the
probe for hybridization overnight at 65–70 °C. The embryos were
thoroughly washed and blocked in PI buffer (PBT, 2 mg/ml BSA, 0.02%
sheep serum) and incubated with anti-Digoxigenin antibody conju-
gated with alkaline phosphatase (Roche) at a dilution of 1:5000
overnight at 4 °C. The embryos were then washed several times with
PBT, and the color reaction was developed with NBT and BCIP.
APP mutation constructs
APP695 construct in pSG5was used as a template (a kind gift of Drs.
Annaert and De Strooper). Brieﬂy, APP695 insert was sub-cloned into
pCS2+ vector between Stu1 and Xba1 sites using a PCR strategy with
forward primer 5′-TTCCATAGGCCTATGCTGCCCGGTTTGGCACTG-3′
and reverse primer 5′-GACCTGTCTAGACTAGTTCTGCATCTGCTCA-3′.
The deletion mutant CΔ18, and sAPPαwere generated by introducing
a stop codon after M677 of APP695 using the reverse primer 5′-
GACCATTCTAGACTACATCTTGGACAGGTGGCGCTC-3′, and after K612
using 5′-GACCTCTCTAGACTATTTTTGATGATGAACTTCATATTC-3′, re-
spectively. APPswe was sub-cloned into pCS2+ using the same
strategy and primers were the same as for APP695.
mRNA preparation
The pCS2+ constructs were linearized with NotI, puriﬁed using a
QIAquick Gel puriﬁcation kit (Qiagen), and sense mRNAs wereprepared using the SP6 mMessage Machine kit (Ambion) according
to the manufacturer's protocol. The mRNAs were quantiﬁed using an
absorbance of 260 nm, and the 260/280 ratio was used to assess
quality.
mRNA injections
Embryos at the 1–2 cell stage were injected with APPb-MO and
then immediately injected again with 80–120 pg mRNA. The amount
of mRNAs injected into embryos was titrated to ensure that themRNA
alone did not give rise to any phenotype. The control sets were either
not injected, injected with MO alone, or injected with GFP mRNA to
conﬁrm mRNA expression. All statistical analysis was done using
Prism 4.0 software.
Microscopy and image analysis
Bright ﬁeld images were taken on a SPOT camera mounted on a
Zeiss Axioplan 2 imaging microscope. The embryos were assessed
without blinding in case of whole embryo morphology and with
blinding in case of in situ observations. Embryos in the mRNA-
mediated rescue experiments were assessed for correction of the
curly tail phenotype. The montages were prepared using Adobe
Photoshop CS2 software. The images were dodged at the background
without losing information.
Western blotting
Fish embryos at different stages of development beginning at
24 hpf were dechorionated, and 50 embryos were collected in a tube.
They were deyolked by triturating in E3 medium (5 mM NaCl,
0.17mMKCl, 0.33mMCaCl2, 0.33mMMgSO4) containing 1mMEDTA
and 0.3 mM PMSF. Embryos were then boiled in 100 μl of 1× SDS
sample buffer (0.063 M Tris–Cl pH 6.8, 10% glycerol, 3.5% SDS and
0.05% 2-mercaptoethanol) for 5 min. The ﬁsh protein samples were
resolved by SDS-PAGE on a 10% gel and transferred on nitrocellulose
membrane. An antigen retrieval procedure was performed as
described (Ryan and Pimplikar, 2005). The blots were probed with
anti-APP-C-terminal antibody (anti-C) at a dilution of 1:2500
followed by incubation with secondary antibody conjugated with
HRP (Jackson Immunoresearch). The signal was developed using an
ECL kit (GE Healthcare). The amount of protein loaded in each lane
was assessed with α-tubulin, DM1A (Sigma) antibody.
Multiple alignment and phylogenetic analysis
MacVector 7.2.2 software was used for generating all alignments
that were used for calculating the evolutionary distances and
constructing the phylogenetic trees. ClustalW algorithm at default
settings was used for generating multiple alignments between
sequences. All analysis was done at default settings. Bootstrap=1000
and UPGMA matrix were used to assess the variation in alignments.
These gave similar results for phylogenies. The sequences were
obtained from the Protein database at ncbi.nlm.nih.gov. Blastp was
used for percentage homology assessments.
Results
APP orthologues and homology in Zebraﬁsh
Zebraﬁsh have two APP homologues, APPa and APPb (Musa et al.,
2001), with similar domain structures as mammalian APP: a large
extracellular domain, a single pass transmembrane segment, and a
short, cytoplasmic tail (Fig. 1). Zebraﬁsh APPb, the product of a gene
located on chromosome 9, is a 694-residue-long protein, whereas the
APPa gene is located on chromosome 1 and encodes for a 738-residue-
Fig. 1. Homology and phylogenetic analysis of APP. (A) Schematic representation of zebraﬁsh APPb and the truncation mutants of human APP used in this study. Zebraﬁsh APPb is a
694-residue-long protein with the extracellular N-terminal domain, a transmembrane domain (shown by the vertical dashed lines), and an intracellular C-terminal domain that
contains the EYNPTY motif (red box). APP family proteins show 3 highly conserved domains (blue regions) that are more than 80% identical among each other, and are separated by
less conserved regions (green regions) that are less than 40% identical at the protein level. APPa contains a 40-residue-long KPI domain (shown in purple), which is not present in
APPb. The location of the Swedish mutation in APP (where residues ‘KM’ are mutated to ‘NL’) is shown by an ⁎. APP-CΔ18 lacks the last 18 C-terminal residues, including the EYNPTY
motif. Soluble sAPPα, which is truncated at the α-cleavage site and lacks both the membrane-spanning domain and the intracellular domain. The percentage homology is obtained
by using Blast at ncbi.nlm.nih.gov or ClustalW in MacVector 7.2.2, both using Blosum matrices. (B) Phylogenetic groupings between APP family proteins from different species. The
tree was generated by using default settings following multiple alignment using ClustalW and Neighbor-joining algorithms. Zebraﬁsh APPa and APPb group closer with mouse and
human APP compared to invertebrate APP proteins. (C) Zebraﬁsh APP levels increase during embryogenesis. Western blot analysis of zebraﬁsh proteins at different stages of
development. Deyolked embryos were collected at the indicated hpf, resolved by SDS-PAGE, and probed with anti-C-terminal antibody that was raised to the last 15 residues of
human APP. Total protein homogenate from a mouse brain was loaded in lane 1 as a positive control. Like mouse APP, zebraﬁsh APP migrates as a closely spaced doublet at
∼100–110 kDa. The lower part of the nitrocellulose membrane was probed with anti-α-tubulin antibody (DM1A).
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APPb more closely resembles human APP695 that is expressed
exclusively in the mammalian brain, while the presence of the KPI
domainmakes APPamore similar to the human APP770 isoform, which
is expressed ubiquitously. The ‘Swedish mutation’ (APPswe) in
human APP changes the lys-met residues to asn-leu at the β-secretase
site (indicated by ⁎ in Fig. 1) and causes familial AD.
Protein sequence alignment of APPa and APPb displays 72%
identity between them and 63–66% overall identity with mouse or
human APP. The three conserved domains (shown in blue in Fig. 1A),
have at least 80% identity amongst ﬁsh, mouse and human and are
separated by less conserved regions (Fig. 1A, shown in green). The
C-terminal region shows 92% identity and 100% similarity, suggesting
that the intracellular domain performs an important and conserved
function. The zebraﬁsh APP genes are evolutionarily closer to
mammalian orthologues, as compared to C. elegans or Drosophila,
and segregate as a separate branch (Fig. 1B). Thus, zebraﬁsh offers aFig. 2. Knockdown of APPa and APPb results in convergent-extension defects. (A) Lateral view
uninjected (1) or injected with control morpholino (2), or injected with a mixture of 5 ng e
embryos, embryos injected with APPa and APPbmorpholinos have dramatic phenotypic chan
function is required for normal convergent-extension movements. Embryos were uninjecte
(each panel 3) or a high dose (each panel 4, 5) of APPa and APPb-MO mixture. (B) Embryos
RNA probe. Uninjected or control-MO-injected embryos have a thin, long, and straight not
embryos (3), and dramatically crooked in the high dose embryos (4, 5). At the higherMO dos
(C) Embryos were ﬁxed at the 4–6 somite stage (12 hpf) and labeled with paraxial protocad
function results in wider somites in a dose-dependent manner. (D) Embryos were ﬁxed at
embryos, the MO-injected embryos have a short tail (3) and severely deformed and widenhighly relevant, yet relatively simple model system to study the in
vivo functions of APP.
Previous in situ studies show that both appa and appb mRNAs are
expressed in the entire embryo at mid-to-late gastrulation (Musa et
al., 2001). During segmentation stages they are co-expressed in the
caudal brain, but selectively in the developing somatic mesoderm
(appa) and posterior neural tube (appb). Transgenic ﬁsh expressing
GFP from the appb promoter gave similar results (Lee and Cole, 2007).
We examined APP expression at the protein level by analyzing total
protein extracts with SDS-PAGE followed by Western blotting. We
used an antibody raised against the C-terminal 15 residues that are
identical in human APP and zebraﬁsh APPb. Fig. 1C shows that APP
protein expression increased from 24 to 72 hpf (Fig. 1C, upper panel,
lanes 2–6) relative to tubulin levels (lower panel). Like mouse APP
(Fig. 1C, lane 1), zebraﬁsh APP migrates as a doublet of approximately
100–110 kDa. It is not known whether these two bands represent
APPa and APPb, or differentially glycosylated forms of the same genes, anterior to the left and dorsal up, of live embryos visualized at 48 hpf. Embryos were
ach of APPa-MO and APPb-MO (3). Compared to the uninjected or control-MO-injected
ges that include a short body axis, a short curly tail, and small eyes. (B–D) Zebraﬁsh APP
d (each panel 1), injected with control-MO (each panel 2), or injected with a low dose
were ﬁxed at the tail-bud stage (10 hpf) and labeled with type II Collagen 1-α (col2a1)
ochord (arrows). The notochord is slightly thicker and misshaped in the low dose MO
e, endodermal precursor cells (arrowheads) are found further away from the notochord.
herin (papc) RNA probe. Brackets in each panel show somite width. Knock down of APP
24 hpf and labeled with α-tropomyosin (tpma) RNA probe. Compared to the control
ed myotomes, especially at the higher MO dose.
Fig. 3. Knock down of APPb protein alone causes aberrant convergent-extension movements. (A) Knock down of APP levels by APPb-MO. Embryos were uninjected (lane 1) or
injected with control-MO (lane 2) or with 5 ng (lane 3) or 10 ng (lane 4) of APPb-MO at the 1–2 cell stage, and harvested 48 hpf. Total protein extract was prepared from deyolked
embryos and analyzed by SDS-PAGE andWestern blot using anti C-terminal antibody. There is a dramatic reduction in APP levels (top panel) in APPb-MO-injected embryos (lanes 3, 4)
compared to the controls. The same membrane was stripped and reprobed with anti-tubulin antibody (bottom panel). (B) Aberrant development in APPb knock down embryos.
Morphology of live embryos at 24 hpf. Lateral views, anterior to the left and dorsal to the top. Embryos were uninjected (1), or injectedwith control-MO (2), or APPb-MO at 10 ng (3).
Compared to uninjected or control-MO-injected embryos, APPb-MO-injected embryos had a shorter body axis and a deformed tail. At highmagniﬁcation, the tail region of APPb-MO-
injected embryos (6) show undulating curvature (highlighted by dotted lines) and deformed somites (4, 5). Scale bars are represented on the top right on the left panel, and equal
0.5 mm. (C) The curly tail defect is more pronounced at 48 hpf. Lateral views, anterior to the left and dorsal to the top, of live embryos at 48 hpf. Compared with uninjected (1) or
control-MO-injected embryos (2), APPb-MO-injected embryos exhibit severely reduced body length and a short, curly tail (3; shownwith thin black lines fromhind yolk to the tail tip
in each embryo). At high magniﬁcation, a mass of disorganized cells could be visualized at the tail tip (black arrow in 6) These abnormal growths were sometimes seen in the APPb-
MO-injected embryos, but never in control embryos. An even higher magniﬁcation of the notochordal region of the tail reveals severe undulations in APPb-MO-injected embryos
(shown by arrows in 9), not present in uninjected (7) and control-MO-injected embryos (8). (D) Aberrant notochord development in APPb knock down embryos. Embryoswere ﬁxed
24 hpf and labeled with an RNA probe for sonic hedgehog (shh), a marker for notochordal and ﬂoor plate cells. Arrows show severely undulating notochord in APPb-MO-injected
embryos (3) compared to control embryos (1, 2).
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Table 2
In situ analysis with tpma at 24 hpf.
Morpholino Dose Percentage of embryos with phenotype
Normal Mild Moderate Severe
Uninjected – 100 – – –
Control-MO 10 ng 100 – – –
APPa-MO+APPb-MO 5 ng 7 58 21 14
APPa-MO+APPb-MO 10 ng – 30 30 40
6 P. Joshi et al. / Developmental Biology 335 (2009) 1–11product. Thus, APP expression is increased relative to tubulin during
embryogenesis.
Aberrent convergent-extension in APPa and APPb knock down
morphants
To examine the role of APP during development, we knocked
down the protein expression by injecting antisense morpholino
oligonucleotides against APPa and APPb (referred as APPa-MO and
APPb-MO). The MO were injected into zebraﬁsh embryos at the 1–2
cell stage, and embryonic morphology observed by light microscopy
at different time points. At 48 hpf, the uninjected embryos appeared
to be normal, with properly developed head and eyes, an elongated
body axis, and a long tail (Fig. 2A-1). Embryos injected with control-
MOdeveloped essentially similar to the uninjected embryos (Fig. 2A-2).
By contrast, embryos injected with 5 ng each of APPa-MO and APPb-
MO exhibited a shortened body axis, a short, curly tail, and mild
synopthalmia (Fig. 2A-3). We observed a similar but less pronounced
phenotype at 24 hpf (data not shown; see also Fig. 3B).
A possible cause of the shortened embryonic axis could be
defective convergent-extension movements. During gastrulation,
cells move dorsally and intercalate medially, causing the spherical
embryo to become thin and to elongate along the anterior–posterior
(A–P) axis (Solnica-Krezel, 2006). To examine whether this process
was affected in APP morphants, we ﬁxed the embryos at different
stages of embryonic development and performed in situ hybridization
analysis for genes expressed in different tissue layers. Uninjected or
control-MO injected embryos (‘control embryos’) at the tail-bud
somite stage contained collagen type II, alpha-1a (col2α1a) expressing
cells in a long, smooth line that corresponds to the developing
notochord (arrows in Fig. 2B-1, 2). By contrast, the notochord in APP
morphants appeared as a wavy, undulating stripe along the A–P axis
(arrows in Fig. 2B-3, 4, 5). The notochord in control embryos was only
one cell wide, while it was often two or more cells wide in the APP-
depleted embryos. The severity of the notochord phenotype increased
in a dose-dependent manner (compare Fig. 2B-3 and B-4 or B-5). In
some embryos at the highest doses, the notochord in APP morphants
seemed split or bifurcated (Fig. 2B-5). col2a1 is also expressed in the
endodermal precursors cells that lie symmetrically on either side of
the anterior notochord (arrowheads, Fig. 2B-1, 2). In embryos injected
with APP-MO, the col2a1-positive cells were scattered further away
from the midline (arrowheads in Fig. 2B-4 and B-5), suggesting their
dorsal convergence was disrupted.
We corroborated these results by examining the expression
patterns of paraxial protocadherin (papc) (Fig. 2C) and α-tropomy-
osin (tpma) genes (Fig. 2D), and found the patterns to be consistent
with defective convergent-extension. The papc-expressing somatic
mesoderm cells in APP morphant embryos were in a wider domain
(shown by brackets) compared to control embryos (Fig. 2C-1, 2), and
the width increases with the dose of theMO (Fig. 2C-3 vs. C-4 and C-5).
Quantiﬁcation of these data demonstrates that at the lower dose, only
17% of embryos displayed a severe phenotype, while approximately
56% of embryos were affected at a higher dose (Table 1). The
expression pattern of tpma in myotomes in APP morphant embryos
was also consistent with a defective convergent-extension process
(Fig. 2D-1 through D-5), which increased in severity to as high as 40%Table 1
In situ analysis with papc at 6 somite stage.
Morpholino Dose Percentage of embryos with phenotype
Normal Mild Moderate Severe
Uninjected – 100 – – –
Control-MO 10 ng 100
APPa-MO+APPb-MO 5 ng 12 – 71 17
APPa-MO+APPb-MO 10 ng 6 – 38 56(Table 2). Since somitewidth is regulated by the degree of convergent-
extension during gastrulation (Pourquie, 2001), these results further
indicate that APP function is required for the normal convergent-
extension movements in zebraﬁsh development.
Knockdown of APPb alone causes defective convergent-extension
movements
APPa and APPb can be differentiated by the presence or absence of
the KPI domain and a differential spatial distribution during develop-
ment (Musa et al., 2001).We next knocked down the expression of APP
individually to examine the contribution of each gene product. Injecting
APPa-MO showed no or mild defects in developing embryos (Supple-
mentary Fig. 1) whereas APPb-MO caused phenotypic changes similar
to those observed when both morpholinos were injected together
(Supplementary Fig. 1). Therefore, subsequent studies were performed
by injecting APPb-MO alone.We determined the effectiveness of APPb-
MO on knocking down APP protein levels. Embryos were injected with
indicated MO, and total protein extracts from embryos (48 hpf) were
separated by SDS-PAGE and probed with anti-C antibody. APPb-MO-
injected embryos had dramatically reduced APP levels when compared
to control embryos (Fig. 3A, upper panel; compare lanes 1, 2 vs. 3, 4).
The lower band in the APP doublet was completely absent, whereas the
intensity of the upper bandwas signiﬁcantly reduced. APPb-MO had no
effect on tubulin levels (Fig. 3A; lower panel). Together, these ﬁndings
indicate that injection of APPb-MO alone signiﬁcantly inhibits APP
expression for up to 48 hpf.
We next studied the development of the APP morphants by
inspecting live embryos in light microscopy. At 24 hpf (20-somite
stage), the control embryos showed normal body axes and tails (Fig.
3B-1, 2) whereas the APPb morpholino-injected embryos exhibited a
short body axis, severally reduced hind yolk (indicated by ⁎), and a
deformed, curly tail (Fig. 3B-3). This phenotype was virtually identical
to that observed when embryos where co-injected with APPa and
APPb. Under high magniﬁcation, the tail region in control embryos
revealed a slightly curved notochord (dotted lines in Fig. 3B-4, 5) and
a ‘stack of pennies’ appearance. By contrast, APPb-MO-injected
embryos exhibited pronounced undulations in the notochord (white
dotted line in Fig. 3B-6) and misshapen somites. At 48 hpf, these
defects were even more pronounced at 48 hpf when the APPb
morphants showed a severely shortened body axis (Fig. 3C- compare
1, 2 vs. 3). The posterior region was characterized by a wavy, curly tail
(Fig. 3C-6), and occasionally a mass of cells was visible at the tip
(arrow in 3C-6). A straight notochord was apparent in the control
embryos (Fig. 3C-7, 8), whereas the notochord was severely
undulating in APPb-MO-injected embryos (arrows in Fig. 3C-9).
To gain more insight into the morphant phenotype, we performed
in situ hybridization to detect sonic hedgehog (shh) expressed by
notochord and ﬂoor plate cells. In situ hybridization with shh revealed
a wavy, undulating notochord in APPb morphant embryos (Fig. 3D-3)
compared to the uninjected or control-MO-injected embryos (Fig. 3D-
1, 2). We also examined the patterning of papc-expressing cells, and
noticed widening of somites similar to that observed in APPa and
APPb combined morphants (date not shown; also see Fig. 5A).
Together, these data show that knock down of APPb alone results in
defective convergent-extension.
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morphants
Since human APP695 shows signiﬁcant sequence homology with
zebraﬁsh APPb, we next asked whether ectopic expression of human
APP could reverse the effects of APPb knock down, and rescue the
defective phenotype. It is often observed that MO injections result in a
‘spectrum’ of phenotypes and injection of APPb-MO also resulted in
embryos that expressed a wide range in the severity of defects. We
scored the resultant embryos as showing mild, medium or severe
phenotypes, according to an arbitrary scale (Supplementary Fig. 4) to
yield semi-quantitative data. The embryos with a ‘mild’ phenotype
looked indistinguishable or similar to control embryos, whereas those
with a ‘severe’ phenotype were approximately half the length of
controls, with no hind yolk and a tail that did not extend out from the
body. Embryos with a ‘moderate’ phenotype fell between these two
extremes.
We ﬁrst optimized the dose of injected mRNA encoding APP695 (or
its mutant constructs) to ensure that injection of mRNA alone does
not induce phenotypic changes. We injected increasing amounts ofFig. 4. Ectopic expression of human APP695 rescues the APPb morphant phenotype.( A) M
Embryos were uninjected (1), control-MO-injected (2), APPb-MO-injected (3), or co-injec
rescued the developmental defects. A higher magniﬁcation of the tail region showed an e
embryos, compared to an undulating notochord and a curly tail in APPb-MO-injected embryo
tail and ‘stack of pennies’ notochord that is similar to controls. (B) Quantiﬁcation of embryo r
phenotype (shortened axis, curly tail) in 75% of embryos (blue bars). Co-injection with mRN
phenotypes, compared to APPb-MO-injected embryos (blue bars) that have increased mode
APP695 mRNA. ⁎⁎⁎ is p=0.0002, pb0.05 in two-tailed unpaired t-test; Gaussian distribution;
MO with sAPPα ectodomain (green bars) showed an increase in normal-to-mild phenotypes in
testN of experiments=8. TotalN of embryos analyzed=143. In contrast, cΔ18mRNA co-injec
injected embryos, indicating cΔ18 mRNA does not rescue the morphant phenotype. pN0.05, MmRNA (from 125 pg to 1 ng) and observed the embryos at
approximately 36–48 hpf. Injection of APP695 mRNA up to 150 pg
dose showed no adverse effects on the development whereas at
250 pg or higher levels (Supplementary Fig. 3) caused the embryos to
show the ‘posteriorized’ phenotype (smaller head, prominent tail,
undulating notochord). Interestingly, knockdown of APP produced
embryos with severely shortened tail (Fig. 2). We also injected mRNA
encoding variousmutant constructs (see Fig. 1) and observed that like
APP695, injection of these mRNA at 150 pg or less produced no
phenotypic changes. At 250 pg dose or higher, sAPPa and APPswe and
to a lesser extent CΔ18, resulted in posteriorized embryos (for
quantiﬁcation see Supplementary Fig. 4). Since none of the mRNA
showed any effects below 150 pg dose, the rescue experiments
described below were performed by co-injected 60–120 pg mRNA.
We co-injected APPb-MO with 5′-capped human APP695 mRNA
(zebraﬁsh APP-MO does not have sequence homology to the human
APP mRNA sequences), and inspected the embryos at 48 hpf. The vast
majority of control embryos developed normally, with a long body
axis (Fig. 4A-1, 2) whereas APPb-MO-injected embryos showed the
defective phenotype (Fig. 4A-3). However, the defective phenotypeorphology of live embryos at 48 hpf. Lateral views, anterior to the left and dorsal up.
ted with APPb-MO and APP695 mRNA (4). Note that co-injection with APP695 mRNA
longated ‘stack of pennies’ notochord in uninjected (5) and control-MO-injected (6)
s (7). Embryos co-injected with APPb-MO and APP695 mRNA (8) revert to an elongated
escue through co-injection of mRNA. Injection of 10 ng of APPb-MO causes the defective
A encoding full-length APP695 (purple bars) results in an increase in the normal-to-mild
rate-to-severe phenotypes, indicating rescue of the curly tail morphant phenotype with
N of experiments=14; N of embryos ∼300. Similarly, embryos co-injected with APPb-
comparison to APPb-MO-injected embryos. ⁎⁎p=0.0037 for sAPPαwith Mann–Whitney
ted embryos (red bars) had a similar number of normal-to-mild phenotypes as APPb-MO-
ann–Whitney test for cΔ18. Error bars represent±standard error of mean (S.E.M).
8 P. Joshi et al. / Developmental Biology 335 (2009) 1–11largely disappeared when embryos were co-injected with mRNA
expressing human APP695 (Fig. 4A-4). The tail of the majority of the
‘rescued’ embryos (Fig. 4A-5 through A-8) was morphologically
similar to the control embryos, while few embryos showed partial
rescue (incompletely restored tail). Quantiﬁcation of these data (Fig.
4B) indicated that 70–80% of embryos displayed amoderate-to-severe
phenotype when injected with 10 ng APPb-MO. When co-injected
with 80–160 pg of APP695 mRNA, less than 30% embryos displayed the
defective phenotype (Fig. 4). We performed in situ hybridization
analysis of the rescued embryos to conﬁrm that human APP prevented
convergent-extension defects. As observed earlier, embryos injected
with APPb-MO alone displayed wider somites (Fig. 5B-2) compared to
control embryos (Fig. 5B-1) when probed with papc RNA probe. This
defect was largely rescued when co-injected with APP695 mRNA (Fig.
5B-3). In situ hybridization using tpma RNA probe also revealed
similar defects (Fig. 5C-1 through C-3). Together, these results
indicate that human APP695 can functionally replace zebraﬁsh APPb
in developing embryos.Fig. 5. APPswe does not rescue APPb morphant phenotype. (A) Quantiﬁcation of embryos
embryos injected with APPb-MO alone appeared normal (blue bars), co-injection with wild
concomitant decrease in the number of embryos showing the severe phenotype. However, w
embryos with normal phenotype, nor was there any decrease in embryos showing the se
between APPb-MO-injected embryos and those co-injected with APP695 mRNA. (B, C) APPsw
ﬁxed at 12 hpf and labeled with papc RNA probe (B) or ﬁxed at 14 hpf and labeled with tpm
somites in APPb-MO-injected embryos (2), which appear normal in embryos co-injected wit
tpma at the 6–8 somite stage showwider myotomal precursors and midline in APPb-MO-inje
(3) but not APPswe (4) reverses the increased width of the myotomal precursors and midlTo identify the APP region that was important for rescue, we
injected APPb-MO with mRNA encoding for a truncated APP mutant.
APP is predominantly cleaved at the α-secretase site to generate
sAPPα, which rescues the lethal phenotype in C. elegans and defects in
APP-KO mice (Hornsten et al., 2007; Ring et al., 2007). Co-injection of
mRNA coding for sAPPα with APPb-MO rescued the short, curly tail
phenotype observed in APPb morphant embryos (Fig. 4B, green bar).
Ectopic expression of sAPPα also increased the number of embryos
with normal-to-mild phenotype from 22% to 60% (p=0.0018, Mann–
Whitney test; N of experiments=6; mean±S.E.M. of percentage of
normal-to-mild phenotypes=58±7.2; for morphology see Supple-
mentary Fig. 5). We also co-injected mRNA encoding APP695 that
lacked the C-terminal 18 residues, including the conserved EYNPTY
motif. Surprisingly, this mRNA did not rescue the APPb morphant
phenotype to any signiﬁcant extent (mean±S.E.M. of percentage of
normal-to-mildly affected embryos=18±8.6; Fig. 4B). We con-
ﬁrmed that APP lacking the C-terminal 18 residues trafﬁcked normally
to cell surface in vitro in tissue culture cells (Supplementary Fig. 6).showing rescue from the short, curly tail phenotype. Whereas approximately 25% of
-type APP695 mRNA (purple bars) showed over 50% embryos to be normal. There was a
hen injected with the same amount of mRNA encoding APPswe, there was no increase in
vere phenotype (yellow bars). pN0.05 by ANOVA. Error bars are ±S.E.M. ⁎⁎pb0.0044
e mRNA does not rescue the defective convergent-extension phenotype. Embryos were
a RNA probe (C). In situ hybridization with papc at the 4–6-somite stage reveals wider
h APP695 mRNA (3) but not with APPswe mRNA (4). Similarly, in situ hybridization with
cted embryos (2) compared to uninjected embryos (1). Co-injection with APP695 mRNA
ine to near the width in uninjected embryos.
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body, curly tail’ phenotype to a large extent, the intracellular domain
of APP was also required to achieve a complete rescue from the
convergent-extension defects of APP deﬁcient embryos.
APP with Swedish mutation (APPswe) does not rescue the curly tail
phenotype of APP morphants
Mutations in APP cause fAD, but it is not known to what degree the
altered polypeptides retain the normal physiological function of APP.
The absence of this information mostly stems from the lack of an in
vivo system to study APP function. Having established that wild-type
human APP was able to replace the function of zebraﬁsh APP, we next
examined whether APPswe also rescued the phenotypic effects of APP
knock down. The APPswe mutant (for annotation see Fig. 1), one of
themost studied fADmutant APP, carries mutations at the β-secretase
site (lys-met residues replaced by asn-leu) and undergoes increased
β-processing. We co-injected embryos with APPb-MO with or
without mRNA coding for APP695 or APPswe, and inspected them at
24 hpf. We observed that whereas wild-type APP695 corrected the
short axis, curly tail phenotype, injecting the same dose of APPswe
mRNA was unable to do so. We scored these embryos to obtain semi-
quantitative data on the severity of the phenotype and the extent of
rescue (Fig. 5A). When injected with APPb-MO alone, only 20–25% of
embryos displayed a normal-to-mild phenotype. When co-injected
with mRNA coding for wild-type APP695, the number of normal
embryos increased to 55–60%. By contrast, co-injection with APPswe
mRNA did not increase the number of normal embryos, suggesting
APPswe lacked function in this in vivo system (Fig. 5A). We also
injected increasing amounts of mRNA into normal embryos to
examine the effects of protein overexpression. Compared to APP695,
APPswe overexpression caused a milder phenotype at each dosage.
Together, these data show that APPswe activity can be differentiated
from that of wild-type APP in developing zebraﬁsh.
We also performed in situ analysis to see whether the lack of
rescue by APPswe was also reﬂected in defective convergent-
extensionmovements. The embryoswereﬁxed at 12–14hpf (6–8 somite
stage), and processed for in situ hybridization with papc (Fig. 5B) or
tpma (Fig. 5C). Whereas the defects caused by injecting APPb-MO
alone (Fig. 5B-2, C-2) were largely corrected when co-injected with
APP695 mRNA, APPswe mRNA was not able to correct the
convergent-extension defects (compare 3 vs. 4 in Figs. 5B and C).
Together, these results suggest that while full-length human APP695
was able to restore APP function in developing zebraﬁsh, APPswe
was not able to do so.
Discussion
In this study, we demonstrate that knock down of APP with
antisense morpholino oligonucleotides caused defective convergent-
extension movements, resulting in embryos with a short body axis, a
short curly tail, an undulating notochord, and wider somites. Ectopic
expression of human APP reversed the APP morphant phenotype,
suggesting that APP function between the human and zebraﬁsh
proteins is conserved. The N-terminal extracellular domain of APP
rescued the defective phenotype to a large extent, while APP lacking
the C-terminal 18 residues did not. More importantly, APPswe failed
to rescue the APP morphant phenotype, indicating that wild-type APP
and APPswe differ in their biological activities.
There are two important outcomes of these studies. First, we have
established that zebraﬁsh provides a powerful in vivo system to
uncover the normal functions of APP. APP has been intensely studied,
but more attention has been directed towards its role in AD pathology,
and less toward its normal biological functions. Our study shows that
APP function is required for normal convergent-extension move-
ments. During gastrulation, convergent-extension occurs mainlythrough the dorsal convergence of cells in three germ layers and
medial intercalation of these cells, causing the embryo to elongate
along the anterior–posterior axis (Wallingford et al., 2002). Our APP
morphants were shorter and wider than normal, as assayed by overall
morphology and the expression of several genes, suggesting that
dorsal convergence and the intercalation of cells were abnormal in the
absence of APP. However, we cannot rule out the possibility that such
phenotype was caused by failure in extension rather than both
convergence and extension and further studies using live imaging will
be required to understand the exact defect.
We do not yet know the precise mechanism by which APP
inﬂuences convergent-extension movements. APP is a transmembrane
protein that is cleaved to release both extracellular and intracellular
fragments. This raises the possibility that APP can act in cell-
autonomous and cell non-autonomous fashion. Moreover, the wide-
spread expression of both appa and appb during gastrulation, makes it
challenging to experimentally determine whether APP is directly or
indirectly involved in regulating these cell movements. Convergent-
extension is orchestrated through speciﬁc signaling and adhesion
molecules, including E-cadherin, glypican 4, and the non-canonicalWnt
signaling pathway (Solnica-Krezel, 2006). One possibility is that APP
interferes with one of these signaling pathways, and our previous
ﬁnding that the APP intracellular domain activates the GSK-3β pathway
would be consistent with this possibility (Ryan and Pimplikar, 2005).
Also, calcium plays a pivotal role in non-canonical Wnt signaling and
convergent-extension movements (Webb and Miller, 2006), and a lack
of APP is shown to perturb calcium signaling (Yang et al., 2007).
Another possibility is that APP affects convergent-extension by
directly regulating cell adhesion or migration. A number of in vitro
and in vivo studies have indicated a role for APP in migration of both
neuronal and non-neuronal cells (Herms et al., 2004; Siemes et al.,
2006; Young-Pearse et al., 2007). Our study extends these ﬁndings
further by showing that a speciﬁc phenomenon, convergent-
extension, is affected when APP function is downregulated. APP
binds F-spondin, which acts as an extracellular guidance molecule
(Burstyn-Cohen et al., 1999), and regulates APP processing (Ho and
Sudhof, 2004; Hoe et al., 2005). The observation that sAPPα rescues
the defective curly tail phenotype is consistent with the studies
performed in other species. Larval lethality in APP-KO in C. elegans can
be rescued by expressing soluble ectodomain (Hornsten et al., 2007).
Similarly, APP ectodomain also rescues the mild phenotypic changes
observed in mice lacking APP (Ring et al., 2007).
Nonetheless, it is puzzling that unlike sAPPα, APP lacking the C-
terminal 18 residues was unable to rescue the APP morphant
phenotype (short body axis, curly tail). This truncation mutant lacks
the conserved GEYNPTY motif, which serves as a docking site for a
number of cytosolic interacting proteins, including Fe65, x11-a, Dab,
Abl, and Jip-1. Since this domain is required for the anterograde
intracellular transport (Satpute-Krishnan et al., 2006), the lack of
rescue by the truncated APP could be due to its inability to participate
in anterograde transport. Although, some studies have shown that
APP-CTF binds kinesin motor protein, which facilitates transport of
APP containing vesicle towards the ‘+’ end of microtubules (Kamal et
al., 2000), these claims have been disputed (Lazarov et al., 2005). We
ﬁnd that CΔ18 mutant is present at the cell surface in transfected in
HEK293 cells (Supplementary Fig. 4) indicating that the truncated
protein can reach the cell surface possibly by the ‘default pathway’
(Schekman and Orci, 1996). The GYENPTY domain is also involved in
sorting, endocytosis, proteolytic processing, and cytoskeletal re-
arrangement (Hoe et al., 2006; King et al., 2003; Muller et al., 2008;
Russo et al., 2005; Scheinfeld et al., 2003). Interaction of APP with
Fe65 (Sabo et al., 2001) or Dab1 (Young-Pearse et al., 2007) or Abl
(Leyssen et al., 2005) is essential for APP to regulate cell movement,
neuronalmigration, and neurite extension, respectively. Thus, binding
of one or more of these proteins may be essential for APP to exert its
role in convergent-extension. Thus it is puzzling why sAPPα, which
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(short body axis, curly tail phenotype). The precise role that APP plays
in cell movements remains a focus of future studies.
The observation that knockdown of APP causes convergent-
extension defects is novel since single APP-KO mice develop fairly
normally and triple-KO mice lacking APP protein family members die
soon after birth. Mice lacking a single APP do show slight anatomical
aberrations in the brain, and exhibit mild phenotypic changes, such as
altered neuromuscular junctions and reduced body weight (Zheng et
al., 1995). The triple-KO mice (lacking all APP family members) show
abnormal migration of cortical neurons and die soon after birth
(Herms et al., 2004). One possibility is that the role of APP in
convergent-extension in mice is made redundant by the presence
other proteins or signaling pathways that are lacking in zebraﬁsh. It is
also possible that the knockout mouse models have not been carefully
examined for mild convergent-extension defects.
A second important aspect of our studies is that by using the
zebraﬁsh system, we are able to distinguish biological activity of wild-
type APP protein from that of APPswe. The Swedish mutation in APP
changes amino acids lysine (K670), and methionine (M671) to
asparagine (N) and leucine (L) respectively. These mutations are
thought to affect the proteolytic processing of APP rendering it
amyloidogenic (Hardy and Selkoe, 2002). However, little is known
about the effect of these mutations on the functionality of the protein,
since the function itself is obscure. To date, approximately 36 familial
mutations that cause AD have been identiﬁed in the APP gene (http://
www.molgen.ua.ac.be/ADMutations/). In the absence of an in vivo
system to evaluate APP function, it has not been possible to determine
whether the fAD mutations in APP represent ‘gain-of-function’ or
‘loss-of-function’ changes in APP. APPswe contains a substitution of
two residues (K670N, M671L) at its cleavage site which alters APP
processing and promotes amyloid production. Our ﬁnding that wild-
type human APP, but not APPswe, was able to rescue the APP
morphant phenotype in zebraﬁsh suggests that APP processing plays
an important role in APP function and that APPswe is functionally
deﬁcient. This notion is also supported by the ﬁnding that over-
expression of APPswe is less potent than wild-type APP in causing the
posteriorized embryos (Supplementary Fig. 5). Although it is not
known precisely how the Swedish mutation in APP causes AD, the
currently favored idea is that APPswe mutant protein undergoes
increased processing at β-cleavage site, resulting in increased
production of Aβ. Our results suggest the possibility that APPswe
may exert changes during embryonic development, which contribute
to the development of AD later in life. Indeed, an epidemiological
study showed that patients who developed late-onset dementia
showed signs of cognitive deﬁcits in early parts of development
(Whalley et al., 2000). Another study showed that the degree of
severity of Spinocerebellar ataxia type 1, a neurodegenerative disease
of typically adult onset, was dependent on prenatal expression of
mutant ATXN1 protein (Serra et al., 2006). We are now conducting
studies to determine whether other familial mutations in APP are also
functionally deﬁcient during zebraﬁsh development.
In summary, we show here that zebraﬁsh provides new insights
into APP function during embryogenesis. Using this system, we have
conﬁrmed earlier observations from other species and further
extended them to show that loss of APP function speciﬁcally affects
convergent-extensionmovements. We also show that this system can
be used to examine the functional activity of mutant APP genes that
cause fAD. Ex-utero development of zebraﬁsh in transparent embryos
should provide a powerful tool to study the function of APP in live
embryos, and could yield novel insights into AD pathogenesis.
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